Some compounds tend to show up in both the lab and the wider world, leaving a mark over the years. (R)-1-(3-Chlorophenyl)-1,3-propanediol found its roots during the surge of synthetic organic chemistry in the mid-20th century, as chemists started mapping out the nuanced world of chiral molecules. The 3-chloro substitution on the phenyl ring provided intriguing possibilities for further chemical manipulation, letting researchers push boundaries on selectivity and reactivity. This molecule has traveled from academic curiosity to backbone in industrial and pharmaceutical research, a testament to persistent curiosity rather than a flash-in-the-pan discovery.
People working at the bench recognize (R)-1-(3-Chlorophenyl)-1,3-propanediol as a chiral diol that connects molecular innovation with on-the-ground needs. Its three-carbon chain with an attached hydroxy group on both ends and a chlorinated, aromatic head let it slot easily into roles as an intermediate for polymers, pharmaceuticals, and specialty chemicals. More than a reagent, this compound often takes part in building blocks for beta-blockers and other cardiovascular drugs. Many also use it in asymmetric synthesis to drive stereochemistry, since the R configuration can push downstream selectivity, which makes a huge difference in bioactivity.
In a flask or bottle, (R)-1-(3-Chlorophenyl)-1,3-propanediol usually appears as a white or off-white crystalline solid, slightly soluble in water, but much more at home in polar organic solvents. Its melting point lands between 98–102 degrees Celsius, providing just enough thermal stability to survive routine handling, but not so stubborn that recrystallization becomes a headache. The presence of two hydroxyl groups introduces moderate hydrogen bonding, boosting both viscosity in solution and its reactivity with acids or base catalysts. Its 3-chlorophenyl ring stands out for selective modifications, like nucleophilic substitution, something many organic chemists enjoy leveraging.
Any reputable supplier delivers technical specifications with precision. Typical bottles arrive labeled with enantiomeric purity (often >98% ee), molecular weight (200.65 g/mol), exact Chiral HPLC traces, detailed NMR data (proton, carbon-13), and chromatographic purity (GC or LC at >99%). Safety sheets spell out all hazard codes, recommended PPE, and emergency procedures. Labels also specify lot numbers, manufacture date, and recommended storage (cool, dry shelf, tightly sealed). These practices let researchers spend less time confirming basics and more time discovering what they care about most.
The synthesis of (R)-1-(3-Chlorophenyl)-1,3-propanediol generally begins with 3-chlorobenzaldehyde, which undergoes asymmetric addition with a chiral catalyst or precursor. One common route employs enantioselective reduction, using a chiral boron or ruthenium catalyst to install the correct configuration at the central carbon. After this step, chemists usually run a gentle hydrolysis, followed by purification through recrystallization or flash chromatography. Many labs favor routes with less hazardous waste. Choosing sustainable catalysts and using less solvent supports greener protocols, something an increasing number of chemists demand.
This compound takes well to derivatization. The aromatic chlorine invites cross-coupling reactions, like Suzuki or Buchwald-Hartwig conditions, letting researchers swap in a range of functional groups. Both hydroxyls open the door for esterification, etherification, or cyclization, leading to ring systems or polyester chains. Reductive amination using the terminal alcohol groups creates aminoalcohol motifs found in drug molecules. These modifications create libraries of analogs, a tactic medicinal chemists use for lead optimization. The stability of the chlorophenyl core under standard conditions means those groups survive through multistep syntheses, making it a favorite scaffold in research.
Catalogs list this compound under several synonyms: (R)-3-chlorophenylpropan-1,3-diol, (R)-1,3-dihydroxy-3-chlorophenylpropane, and sometimes with a specific brand code unique to vendors. In academic papers, its IUPAC name or simple diol descriptor surfaces most often, yet those who work with it know to check CAS numbers and supplier catalog names before ordering, to dodge mix-ups with its racemate or the (S)-enantiomer.
Like any organic intermediate with aromatic and halogenated features, (R)-1-(3-Chlorophenyl)-1,3-propanediol requires diligent handling. SDS sheets list it as an irritant for eyes and mucous membranes. Labs using it must ensure HVAC and wear of gloves, goggles, and lab coats. Any spill means immediate cleanup using absorbent pads and solvent-compatible disposal procedures. Long-term storage takes place out of direct sunlight in amber containers, to limit decomposition. Waste byproducts containing chlorine need correct hazardous management, since halogenated organics create trouble for regular waste streams. Following best practices not only satisfies audits, but more importantly keeps researchers safe.
Its applications run broad. (R)-1-(3-Chlorophenyl)-1,3-propanediol often supports drug discovery as a chiral intermediate, especially for drugs targeting neurological diseases and cardiovascular health. Research groups use it for synthesizing optically active beta-blockers, as its spatial arrangement matches receptor pockets. Polymer chemists sometimes employ it to create specialty polyols with tuned glass transitions for coatings or adhesives. Academic labs test its utility in new catalytic cycle development, as its two hydroxyls and aryl chlorine create countless branching points for organometallic or enzymatic transformation. Its presence in patent filings for new small molecules keeps it in steady industrial demand, especially as chiral purity requirements tighten in drug pipelines.
In the world of R&D, every established compound like this one sees renewed attention as technology advances. High-throughput screening has revealed new enzyme catalysts that process chlorinated aryl diols with improved selectivity and atom economy. Digital modeling informs synthetic planning, letting chemists design modifications to the 3-chlorophenyl ring to probe SAR (structure-activity relationships) and find better drug leads. Some startup biotech companies leverage biocatalysis for producing this compound at scale, using engineered microbes for lower cost and environmental impact. Open data-sharing also leads to new collaborations stretching across academic and industrial spheres, speeding up what once took years.
Studies on (R)-1-(3-Chlorophenyl)-1,3-propanediol generally register low acute toxicity, with neither lethal nor mutagenic effects under standard test conditions. Still, long-term exposure research remains ongoing. Animal trials have not shown major carcinogenic risk, but metabolism studies suggest careful monitoring of chlorinated breakdown products, as persistent halogenated organics can have subtle but real ecological consequences. Chronic exposure studies in workplace settings drive updated threshold limits and encourage continued vigilance in air and skin monitoring. As more data surfaces, safety guidelines keep updating, keeping people and the environment better protected.
The horizon for (R)-1-(3-Chlorophenyl)-1,3-propanediol looks promising, shaped by pressures for sustainable synthesis and rising demand for optically pure pharmaceuticals. Automation reduces tedious purification steps, letting chemists focus on innovation instead of logistics. Machine-learning guides retrosynthesis, pushing for fewer steps and lower environmental impact. Regulatory agencies show growing insistence on green chemistry, so future work likely shifts toward renewable feedstocks and “closed loop” catalysis, where hazardous waste gets minimized or recycled. New frontiers in drug design keep driving interest for novel analogs, with this diol often acting as a trusted lynchpin. For those seeking to push boundaries or just get reliable performance at the bench, it remains a mainstay—tried, trusted, and constantly evolving.
Scientists and chemists run into all kinds of compounds in the search for new medicines and treatments. (R)-1-(3-Chlorophenyl)-1,3-propanediol pops up in research labs more often than people outside science circles might guess. The main reason folks care about this molecule has to do with its role as an intermediate. It shows up while developing other chemicals, especially those heading for the pharmaceutical world.
What sets this compound apart involves its structure — that "R" at the start signals its chirality, or handedness, which plays a huge part in how medicines interact with the human body. For anyone who’s wrestled with allergies or headaches, it’s easy to forget that the pills depend on specific, right-handed or left-handed shapes acting correctly in your body. With this propanediol, chemists use its chiral form to craft more advanced drugs, antibiotics, and pain relievers.
Drugs like chloramphenicol, which helps fight bacterial infections, wouldn’t exist as we know them without building blocks such as this one. In research papers, this compound keeps showing up in paths leading to life-saving treatments. The compound provides part of the skeleton chemists snap together before carefully guiding the rest of the process.
Safety doors matter here. Mistakes made in this part of drug making don't just cost money — they can cost health. In my own time spent around university chemical stockrooms, I picked up a strong respect for the protocols involving any molecule like this. Manufacturers and researchers require purity, clear traceability, and detailed safety information. Contaminants or mix-ups create major headaches, from ruined batches to much bigger downstream issues.
Working with this chemical doesn’t compare to mixing a batch of pancake batter. The presence of chlorine means gloves, goggles, and fume hoods come out every single time. Exposure risks aren’t theoretical. Adventures in chemical synthesis, especially for intermediates set to lead to drugs, demand attention to safety data sheets and clear documentation.
Environmental concerns follow right behind personal ones. Regulations shape what happens to leftover compound. My own lab managed waste meticulously; every drop went to hazardous disposal, never down the drain. Authorities like the EPA enforce this for a reason — these chemicals don't disappear once out of sight. Responsible handling prevents pollution in ground and water, and smart management helps everyone breathe easier.
Chemists always look for cleaner, more efficient ways to make these and similar compounds. Greener chemistry approaches — like using less harmful solvents, recycling waste streams, or engineering more selective catalysts — make a real difference. Industry insiders and academics often trade notes on what works. Bringing down risk to researchers, patients, and communities requires real engagement at every step, not just in the final pill or injection.
The world of drug development relies on substances like (R)-1-(3-Chlorophenyl)-1,3-propanediol, but the story stretches beyond a single molecule. It’s a piece of a much larger system, where thoughtful design, provable safety, and smart choices turn ideas into treatments, and keep dangerous side effects out of our air, water, and medicine cabinets.
The nuts and bolts of (R)-1-(3-Chlorophenyl)-1,3-propanediol tell a story every bit as interesting as any headline. This molecule’s backbone features a three-carbon propanediol chain, which means two hydroxyl (–OH) groups anchor at each end. A 3-chlorophenyl group sits at the first carbon, creating a unique profile. I see the SMILES notation laid out as OC[C@@H](CO)c1cccc(Cl)c1, and as someone who has studied organic chemistry, it stirs memories of painstaking structure drawing in university labs. The “R” tells us about handedness—this molecule reflects light and interacts with the world in a way its mirror image wouldn’t. It’s as if nature gives molecules a left or right shoe, and only the right fit matters for a given purpose.
Most folks can tell you water weighs 18 grams per mole, but ask about (R)-1-(3-Chlorophenyl)-1,3-propanediol and the conversation usually dries up. Here’s the scoop: It clocks in at 204.66 g/mol. I appreciate this number isn’t just trivia. In practical terms, I once helped a formulation chemist calculate doses for a project, and getting the molecular weight right meant the difference between a solid protocol and a failed experiment. The value comes from tallying up the pieces: carbon, hydrogen, chlorine, and oxygen. Each element pulls its own weight, and the sum gives manufacturers and researchers a clear target.
I’ve watched the hands-on folks—technicians in drug discovery, compliance officers in chemical safety, even waste management workers—use molecular details like structure and weight to shape decisions. The structure tells you how the molecule fits into reactions or blocks enzymes. It can predict toxicity. Toxicological databases rely on exact matches; misidentifying a chloro- group or chirality changes risk profiles. Folklore in labs suggests a missing detail can force whole batches back to the start, wasting time and money. So drilling down into this information saves resources for companies and protects end users.
Problems usually jump out when people skip steps. I remember an incident where a coworker used a racemic mixture rather than the (R)-specific compound. Downstream effects caused lost weeks in research, simply because the specifics got glossed over. Companies could swap out protocols for better controls. Double-checking chirality, running NMR or chiral HPLC, and using reputable suppliers lowers the risk. It’s not just about following rules; mistakes cost real dollars and sometimes even lead to legal claims if a product reaches the market in the wrong form.
It helps to build habits rooted in precision. I advocate for regular staff training, strong supplier vetting, and maintaining updated Material Safety Data Sheets (MSDS). Some labs invest in in-house spectrometers just to cut down on trust issues and short-circuit costly recalls. Automation can flag chiral errors, but having staff with enough knowledge to challenge results makes a real difference. Regulations keep rising; routine oversight isn’t an optional extra— it becomes a business necessity.
So, diving into the chemical structure and weight of (R)-1-(3-Chlorophenyl)-1,3-propanediol does more than scratch a scientific itch. It creates a culture where precision leads to safer, more predictable outcomes—whether in pharmaceuticals, research, or industrial chemistry. Clear structure and accurate mass matter much more than fine print; they help protect investments and, most of all, people.
People who work in labs or with fine chemicals understand chemicals don’t all behave the same. (R)-1-(3-Chlorophenyl)-1,3-propanediol isn’t some household tablet you can leave on a dusty shelf or next to a coffee maker. This compound, with its specific structure, falls into a class containing both phenyl and chlorinated groups. These features might not sound exciting, but they mean one thing: you avoid carelessness and stick to safety rules.
The biggest red flag comes from experience in chemical handling—chlorinated organics tend to hang onto their toxicity, lingering even after minor spills or contamination. With over a decade spent working in research environments, I’ve seen more destroyed experiments and panic moments caused by casual storage than anything else. If you don’t pay attention, contamination can spread in a blink.
Moisture and heat cause all sorts of trouble for chemicals like this. Exposing (R)-1-(3-Chlorophenyl)-1,3-propanediol to damp conditions—leaky basements, humid storage rooms—puts stability at risk. Many researchers keep it in a dedicated chemical fridge or at room temperature away from sunlight. You don’t toss it near radiators, water baths, or on top of an old heater. Experience has shown that temperature swings invite degradation or unexpected reactions, especially in compounds with delicate diol groups.
A desiccator, or even simple silica gel packs in the storage container, makes a difference in fending off creeping moisture. Nobody enjoys opening a chemical jar to find clumps, water droplets, or altered powder. Get in the habit of resealing containers quickly. It takes only a second, and one forgotten jar can ruin a batch costing thousands.
You don’t tuck (R)-1-(3-Chlorophenyl)-1,3-propanediol between acids, bases, or oxidizers. In chemistry labs, separating reactive substances is as old as science itself. Cross-contamination brings danger and ruined research records. The compound thrives in its own sealed, properly labeled bottle—ideally a glass container with a tight-fitting, chemical-resistant cap. Labels ought to show the full name, date received, and person responsible for the batch.
Glass beats plastics for long-term storage unless a manufacturer’s technical sheet says otherwise. Some plastics can leach, crack, or let in trace air or vapors, especially with chlorinated organics. If you want peace of mind or regulatory compliance, always check for chemical compatibility tables before choosing the storage vessel.
Personal experience drives home the importance of gloves, lab coats, and goggles before handling any small bottle taking up space in the chemical fridge. Spills have a nasty habit of happening right as you stop paying attention. Eye or skin contact can mean trouble due to unknown toxicity—data might not cover every long-term exposure risk. If spills do occur, having a spill kit close by cuts panic and risk.
Regular stock checks prevent forgotten compounds from piling up, and digital logs make tracking who last opened each bottle simple. Notification systems—be it an old-fashioned tag or inventory software—remind everyone of expiry or any observed changes. Visible teamwork works much better than cryptic emails no one reads.
Placing safety data sheets on the wall gets more attention than letting them collect dust in a folder. Keeping a batch of tightly sealed, labeled containers on a shelf clear of incompatible materials saves headaches down the road. Regular training and a clear culture of “see something, fix something” have lowered incident rates in every lab where I’ve worked.
Smart, routine steps count for more than any “cutting-edge” gadget. Keep the room dry, check sealed bottles, and always return chemicals to their place. A careful approach pays back every day—through cleaner experiments, saved money, and, most importantly, people heading home from the lab safe and sound.
Many people rarely stop to think about the dozens of complex chemicals that show up in laboratories and manufacturing lines. (R)-1-(3-Chlorophenyl)-1,3-propanediol stands as one of those names that sparks quick Google searches and furrowed brows during safety meetings. Folks working in chemical plants or specialty research facilities sometimes ask one question: Do we need to treat this compound like trouble?
From years spent on lab benches and in storerooms, I’ve learned that most chlorinated organics present challenges, both handling and health-wise. This particular compound draws some attention because of its core structure—a chlorinated aromatic ring fused to a diol backbone. Simple chemistry tells us that the chlorine atom adds both reactivity and potential toxicity.
Looking up toxicity databases and regulatory sheets offers a clearer picture. The European Chemicals Agency (ECHA) and U.S. National Library of Medicine do not currently list this substance with the same hazard symbols that dog notorious compounds like chloroform or dioxins. Still, published research indicates compounds with similar structures may disrupt the liver or central nervous system in high enough doses.
No one can say for certain that (R)-1-(3-Chlorophenyl)-1,3-propanediol falls into the worst offender category. But many in the industry treat any phenyl-chlorine compound with basic respect until strong evidence clears it. Studies from the last decade show that related chlorinated propanediols can break down into smaller fragments that linger in water, soil, or air, sometimes leading to bioaccumulation.
Simple habits go a long way. People working with this chemical usually don gloves, eye protection, and a lab coat. This feels like common sense for any semi-volatile organic compound. Fume hoods or well-ventilated areas cut down on accidental exposures. Spills or splashes—caught early—pose far less risk to people and the workspace.
Looking at the Safety Data Sheets from reputable suppliers, the advice leans conservative. If the material touches skin or splashes into eyes, flush with water for at least 15 minutes. Avoid breathing in any powder or vapor. This guidance mirrors what you’d see for other mid-level industrial organics.
Many companies track and store this compound in clearly labeled, sealed glass or plastic containers—much like any laboratory reagent above a certain hazard threshold. Waste carries over to designated chemical containers, not the general trash or sink. Disposal runs through licensed chemical waste handlers, which fits the pattern for most semi-hazardous lab substances.
People who work with chemicals every day build a sixth sense for what demands caution. In my experience, most accidental exposures happen not from outright danger but from lapses in routine. The challenge with lesser-known compounds like (R)-1-(3-Chlorophenyl)-1,3-propanediol comes from that gray area between full-blown hazard and ordinary risk. We often rely on company protocols rooted in chemical family behavior and the wisdom passed along by seasoned staff.
Safer chemical design stands out as one solution. Reducing the need for chlorinated intermediates, swapping in less persistent alternatives, and investing in education keep the work environment under control. Training new hires to respect not fear, to learn the risks by heart, and treat every bottle of unknown with the right level of caution pushes the culture forward. A balance between overkill and complacency wins every time.
Pharmaceutical and fine chemical labs count on the reliability of every single ingredient, and (R)-1-(3-Chlorophenyl)-1,3-propanediol is no exception. The purity tells more than just what percentage of the sample belongs to the target molecule; it also hints at how carefully it’s been synthesized and tested. Most reputable suppliers list this compound at ≥98% purity, sometimes reaching as high as 99% for projects that demand near-perfect precision. These numbers don’t just give peace of mind—they affect the reaction yields and reduce clean-up steps later on.
A certificate of analysis isn’t just bureaucracy. It lays out details like heavy metal content, residual solvents, and chiral purity. These test results steer researchers clear of unwanted side reactions, off-target biological activity, or failed clinical batches. When the stakes revolve around new drug candidates or key intermediates, a single percentage point in purity can make or break a project’s success. Some labs may get away with a lower threshold for early discovery work, but scaling up almost always means locking in the tightest specs.
There’s a reason you won’t see this compound shipped in bulk sacks or casual containers, even if someone’s ordering kilos. Moisture, light, and oxygen—three enemies hiding around any corner—can chip away at the stability and longevity of sensitive molecules like this one. Most commercial suppliers stick to amber glass bottles, commonly ranging from as little as 1 gram for R&D all the way to multi-hundred-gram packages.
For custom or large-scale jobs, heavy-duty sealed containers often arrive equipped with tamper-evident caps and sometimes nitrogen blanket. These touches help block degradation or cross-contamination. Polypropylene or high-density polyethylene bottles sometimes take the place of glass for large orders, especially if shipping gets rough. Every lab manager and logistics handler will say that well-sealed, properly labeled packaging heads off headaches before they start—especially with tricky customs and hazardous materials rules in play.
Not all listings are cut from the same cloth. Suppliers cutting corners with vague purity claims or skimping on packaging signal trouble ahead. Look for real transparency—batch-specific certificates, track records on delivery, and strong communication about regulatory documentation.
From my own experience in small pharma startups, chasing a better price from an unverified source too often led to wasted time and budget. More than once, the solution lay in adding supplier qualification steps—auditing, sample testing, and alignments on packaging. Investing early in these safety checks pays back once the synthesis ramps up.
One real fix for keeping things on track has been developing procurement standards as part of good manufacturing practice (GMP) procedures. Requiring clear proof of identity and purity for every incoming lot ensures nothing slips through the cracks. Open communication with suppliers about packaging choices also keeps labs from being stuck with fragile bottles or bags that fall short in storage.
At the end of the day, every lab worker deserves to trust the bottle they open. A little diligence in confirming purity and checking packaging specs makes things run smoother for everyone down the line.
Providing high-quality chemical products and logistics solutions for global trade partners.
